Company page
Foghorn Therapeutics Inc.
Foghorn Therapeutics Inc. is a public company traded under the ticker FHTX in the American market. The company has a market capitalization of approximately $243.7 million. Foghorn focuses on developing innovative therapies that target gene regulation to treat various diseases.
- Ticker
- FHTX:NASDAQ
- Asset type
- Stock
- Market cap
- $243.7M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD